A time-modulated frailty model is proposed for analyzing multivariate failure data. The effect of frailties, which may not be constant over time, is discussed. We assume a parametric model for the baseline hazard, but avoid the parametric assumption for the frailty distribution. The well-known connection between survival times and Poisson regression model is used. The parameters of interest are estimated by generalized estimating equations (GEE) or by penalized GEE. Simulation studies show that the procedure is successful to detect the effect of time-modulated frailty. The method is also applied to a placebo controlled randomized clinical trial of gamma interferon, a study of chronic granulomatous disease (CGD).
Introduction
In the analysis of failure time data, one of the common assumptions made is that the life histories for subjects under study are statistically independent (at least conditionally on the observed fixed-time covariates). This assumption may be violated when individuals within some subgroup (e.g. siblings or parents in the same family, litter mates in animal study) share common unmeasured factors. Frailty models have been widely used for correlated survival data after Vaupel et. al. (1979) introduced the concept of frailty for making adjustments for the over-dispersion (heterogeneity) in their mortality study.
A frailty is an unobserved random effect shared by subjects within a subgroup. These include shared frailty (Hougaard, 1986a) , bivariate frailty (Xue, 1998) as well as correlated frailty (Yashin, et. al. 1995) , but few of them deal with time-dependent frailty (Self, 1995; Yau and McGilchrist, 1998) . Most papers in the literature assume that individuals in the same cluster are Pingfu Fu is senior instructor, email address: pxf16@po.cwru.edu. This is a portion of Fu's PhD dissertation. J. Sunil Rao is Associate professor, email address: sunil@hal.cwru.edu. Jiming Jiang is Associate professor, e-mail address: jiang@wald.ucdavis.edu.
born at a certain level of relative frailty and stay at this level through out life. As mentioned by Vaupel et. al. (1979) , this may not be true in reality, for example, in human population mortality study, the frailty of an individual is large during an early period of life, after which it stabilizes, followed by an increasing frailty due to the natural aging process. For univariate frailty model, there are several limitations, for example, the model only allows positive correlations within the cluster, and the unobserved factor (frailty) is the same within the cluster (Xue, 1998) .
Typically we assume that the frailty acts multiplicatively on each individual's hazard rate. We propose a time-modulated frailty model to analyze multivariate failure time data. The proposed model is more general than other frailty models, having as special members regular frailty models, such as shared frailty and bivariate frailty models if we ignore the time-modulated component in the model. Using the well-known connection to Poisson regression (Aitkin and Clayton, 1980) , the derived model is a generalized linear mixed model (glmm). We adopt a robust approach for estimating some parameters using the generalized estimating equations (GEE) in this Poisson regression setting. For other parameters, the estimating procedures are equivalent to a generalized penalized estimating equations (GPEE) . Under this approach, we do not specify the exact distribution of frailty and in this sense, our approach is robust.
Model construction
Self ( process, in the hazard function, we introduce an "interaction" term between the frailty and time as a time-modulated frailty. In the following sections, we will give the model formulation in two different settings.
Single-level of clustering
The most common situation in the multivariate survival data is the time to the recurrence of some chronic disease for a patient, for example, breast cancer, or survival of litters of rats, survival of twins, etc. All these can be thought to consist of single-level clustering of data. The survival times in each cluster (patient, litter, twins) are correlated and the survival times between the clusters are assumed independent. Let the triple (T ik , δ ik , x ik ) represent the data, where i is the cluster index (i = 1, …, n) consisting of correlated survival times T ik (k = 1, … , n i ). Thus, the kth individual in the ith group is modeled as 
Multiple-levels of clustering
In some studies it may be reasonable to expect more than one level of within-cluster association. For example, the association between a parent and child versus that two siblings in studies of familial disease aggregation, or the durations inside and outside of hospitals for a patient who is admitted into a hospital several times for the same disease (Xue, 1998) . The single-level clustering model can be extended to allow for grouping defined by multiple nested factors.
Again, suppose the data consists of the usual triple (T ijk , δ ijk , x ijk ), using i to index the clusters (litters, families) (i = 1, 2, …, n). Each cluster contains two distinguishable subgroups (j = 1, 2). Within each cluster, individuals have correlated survival times T ijk for k = 1, …, n ij . When n ij = 1, then (T i11 , T i21 ) is bivariate survival time, for example, as used in the adult Danish twins study (Hougaard et. al., 1992 
, then it is a case studied by Xue (1998) ; if θ > 0 or θ < 0, then we can see that the effect of frailty increases or decreases as time increases.
As we can see from the model construction in both single-level and multiplelevel of clustering cases, given the frailty, its effect on the hazard changes over time. The details are given in Appendix 1.
Robust estimation procedures
As described in Appendix 1, we can treat the censoring variable as a correlated Poison random variable with degree of over-dispersion depending on its mean. Since the full likelihood method is not feasible without numerical integration, and because of the intractability of the marginal likelihood function, we may apply the generalized estimating equations (GEE) approach (Liang and Zeger, 1986) , which only requires the specification of the first two moments of the responses for each individual.
As mentioned by Hougaard (1984) , the choice of the frailty distribution is crucial since the results for the survival population will be rather different with different frailties. In the following section, we will examine this robust approach, which only requires up to second-order of moments of the frailty distribution. It is robust in the sense that the full likelihood is not required and a fully parametric assumption for the frailty is avoided. The following procedures are for the single-level of clustering case, but they can be easily generalized to the multiple-level clustering case.
Exponential case Estimation of coefficients
We assume that the baseline hazard is from exponential distribution. Given the frailty ξ i as mentioned before, 
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and the unconditional covariance
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In order to get the estimates of the regression parameters, we apply the quasi-likelihood score equations in spirit of GEE, i.e. , 0
, which depends on β and θ in the above equations. Thus, we need the estimating procedure for θ.
Estimation of time-modulated frailty parameters
The estimate of the variance component 2 σ is treated as nuisance parameter, which is estimated by a method of moments defined as
The conditional likelihood function has form: 
is the log of the quasi-likelihood function for correlated Poisson variates.
We then introduce the penalized score equation for the θ, 
Weibull case
When the baseline hazard is assumed to have a Weibull distribution, the model is more flexible by introducing an additional scale parameter ν. ,k l,
Estimation of coefficients
The estimate of the regression parameters can be obtained by the following generalized estimating equations, i.e. n -consistent estimates for ν and θ.
Estimation of other parameters
The estimate of the variance component 2 σ is defined the same way as the exponential case:
The conditional likelihood function in this case has a form Thus, we introduce the penalized score equations for φ as we did in the exponential case,
where the tuning parameter 
which is moment estimate if we replace ik μ by its sample mean. In summary, we propose following algorithm for the estimates of β, φ, ν and θ,
, and fit Poisson regression by generalized estimating equations (4) If we reject the null hypothesis from the test, then we claim that the effect of timemodulated frailty exists. In the following sections, we examine our method by simulation followed by analyzing CGD dataset.
Simulations
There is a difficulty with conducting simulations in this setting, since it's difficult to generate correlated survival times with timemodulated frailties as we can see it in the specification of the hazard function which involves time-modulated frailties.
We generate datasets of correlated Weibull (without time-modulated frailty, i.e. 0 = θ ) by using positive mixing distributions (Hougaard, 1986a) ) ( − = n n κ which is arbitrarily picked. We understand that the optimal choice of the tuning parameter may be selected by many methods, for example, the cross validation approach.
In this correlated Weibull case, as we know, there is no time-modulated frailty in it. We still assume the time-modulated frailty model, and the frailty term is in the form of As we can see from 
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1.781 0.3852 4.624 < 0.0001
The true value of β is 1.8 and 1.2 for ν. BC stands for bias corrected, GJ for grouped jackknife, and SN for Segal and Neuhaus.
A real data example The well-known Chronic Granulomatous Disease (CGD) dataset, which is described in the Appendix D of the book by Fleming and Harrington (1991) , has been analyzed by many authors. CGD is a group of inherited rare disorders of the immune function characterized by recurrent pyogenic infections, which usually present early life and may lead to death in childhood. Phagocytes from CGD patients ingest microorganisms normally but fail to kill them, primarily due to the inability to generate a respiratory burst dependent on the production of superoxide and other toxic oxygen metabolites. Thus, it is the failure to generate microbicidal oxygen metabolites within the phagocytes of CGD patients.
There is evidence that gamma interferon is an important macrophage activating factor which could restore superoxide anion production and bacterial killing by phagocytes in CGD patients. In order to study the ability of gamma interferon to reduce the rate of serious infections, a doubleblinded clinical trial was conducted in which patients were randomized to placebo vs. gamma interferon. The data we use here, which is a little different from the one used by Fleming and Harrington (1991) in the example at page 162, has 65 patients in placebo group, 63 in gamma interferon group, of 30 placebo patients who experienced at least one infection, 4 experienced 2, 4 experienced 3, 1 experienced 4, 1 experienced 5 and 1 experienced 7; of 14 treatment patients who experienced at least one infection, 4 experienced 2 and 1 experienced 3.
It is reasonable to assume that the patients' frailties are time-modulated, since the risk of infection may increase once a first failure event occurs. In this data set, we treat each patient as a cluster, and the frailty term is in the form of The negative value of βˆ= -0.8353 means that the treatment (gamma interferon) effectively reduces the recurrence of pyogenic infections as compare to the placebo. The estimate of β is consistent to that from other approaches. From the estimates of θ and its variance, we can see that there is a time-modulated frailty effect in this dataset as noticed by Self (1995) though we have different model formulations. The parameter estimate of the time-modulated frailty 293 . 1 = θ is statistically significant from 0; the positive sign also means that given the frailty, its effect on the hazard is increasing as the life goes on.
The estimate of the treatment effect β is consistent with other two approaches; all of them indicate a statistically significant difference between the gamma interferon and placebo. The time-modulated frailty model does not seem to improve the efficiency, but the proposed model does help us to understand the nature of the frailty. In CGD case, the existence of effect of timemodulated frailty means that if a patient has a large frailty at the beginning, then (s)he will have an increasing chance of recurrence of pyogenic infections.
Conclusion
Few results about time-modulated frailty models are available in the literature (Yau and McGilchrist, 1998; Self, 1995) . Our model provides one way to detect whether there is a trend in the hazard function with time given the frailty. Our model is different from Yau and McGilchrist's (1998) , which assumes a different frailty for each time period of recurrence of disease; and different from Self's (1995) which introduces a stochastic process of frailty in the hazard function. The models proposed can also be extended in more general case, for example, in the multiple-level of clustering case, the time-modulated frailty can have the following form , ) ( are independent realizations of two independent random variables with positive values. The resulting models are more complex than the one we proposed. To fit this model, we may use techniques of nonlinear mixed-effects models (Pinheiro and Bates, 2000) .
Clinically speaking, the significance of the model is to realize whether there is an effect of time-modulated frailty in some diseases. If it does exist, for example, the pyogenic infection case (CGD data), it will tell us that more frail patients (say, have recurrence at the beginning) are more likely to have recurrence late in their life, which may suggest that those patients need more aggressive treatment (e.g. high dosage). (Liang and Zeger, 1986) and the asymptotic properties are well established in this case. As stated in Liang and Zeger (1986) , under mild regularity conditions, the estimate of βˆ from the generalized estimating equation (1) and (4) Appendix 3: Jackknife variance estimation and bias correction
For the parameter β, we can use the robust estimate building in the existing procedure. The parameter θ is indicator of the effect of timemodulated frailty, and it is our interest to see whether this effect exist, thus we cannot treat it as a nuisance parameter. First, we notice that the estimate of θ is not unbiased because of the penalty term in equation (3) or (6) and 0 ≠ ∂ ∂ θ l E (Page 28, McCullagh and Nelder, 1983) . We will obtain the variance estimate as well an estimation of bias by grouped jackknife method (Therneau and Hamilton, 1997).
The grouped jackknife procedure is the following: Each time we delete the observations from each cluster (or a patient), say cluster i, and obtain the estimate, say , ) (i θ by applying above estimating procedure to the rest of the data. Let θˆ be the estimate based on the all the observations, then the grouped jackknife estimation of variance for θ is , ) ( ) 1 ( ) ( var
